Your email has been successfully added to our mailing list.

×
0 -0.000148148148148154 -9.87654320986756E-05 0 0.00024691358024697 0.00641975308641981 0.00780246913580253 0.00523456790123458
Stock impact report

Abbott seen posting modest Q1 earnings amid Nutrition segment slowdown [Seeking Alpha]

Abbott Laboratories (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
Company Research Source: Seeking Alpha
Quick Insights The acquisition gives Abbott Laboratories access to the $60B US cancer diagnostics market and could boost its own diagnostics segment, which has seen negative growth recently. The Nutrition business is expected to return to growth in the second half, supported by the launch of 8 new products over 12 months, after a sales decline due to market share loss. Most analyst revisions have been downward for both EPS and revenue, signaling limited optimism despite projected modest growth. More Trending News Show less Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ABT alerts
Opt-in for
ABT alerts

from News Quantified
Opt-in for
ABT alerts

from News Quantified